MA51146A - SUBSTITUTED HETEROCYCLIC BICYCLIC COMPOUNDS USED AS PRMT5 INHIBITORS - Google Patents
SUBSTITUTED HETEROCYCLIC BICYCLIC COMPOUNDS USED AS PRMT5 INHIBITORSInfo
- Publication number
- MA51146A MA51146A MA051146A MA51146A MA51146A MA 51146 A MA51146 A MA 51146A MA 051146 A MA051146 A MA 051146A MA 51146 A MA51146 A MA 51146A MA 51146 A MA51146 A MA 51146A
- Authority
- MA
- Morocco
- Prior art keywords
- substituted heterocyclic
- compounds used
- bicyclic compounds
- heterocyclic bicyclic
- prmt5 inhibitors
- Prior art date
Links
- 102100034607 Protein arginine N-methyltransferase 5 Human genes 0.000 title 1
- 101710084427 Protein arginine N-methyltransferase 5 Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201721044886 | 2017-12-13 | ||
| PCT/IB2018/060015 WO2019116302A1 (en) | 2017-12-13 | 2018-12-13 | Substituted bicyclic heterocyclic compounds as prmt5 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA51146A true MA51146A (en) | 2021-03-24 |
| MA51146B1 MA51146B1 (en) | 2022-10-31 |
Family
ID=83995765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51146A MA51146B1 (en) | 2017-12-13 | 2018-12-13 | Bicyclic substituted heterocyclic compounds used as prmt5 inhibitors |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA51146B1 (en) |
-
2018
- 2018-12-13 MA MA51146A patent/MA51146B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA51146B1 (en) | 2022-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA51846A (en) | HETEROCYCLIC COMPOUNDS USED AS KINASE INHIBITORS | |
| MA43169A (en) | HETEROCYCLIC COMPOUNDS USED AS PI3K-GAMMA INHIBITORS | |
| MA51438A (en) | HETEROCYCLIC COMPOUNDS USED AS LSD1 INHIBITORS | |
| MA52486A (en) | PYRIDAZINONES USED AS PARP7 INHIBITORS | |
| MA49888A (en) | MACROCYCLIC COMPOUNDS USED AS KINASE ROS1 INHIBITORS | |
| MA47099A (en) | BICYCLIC HETEROAROMATIC COMPOUNDS USED AS IMMUNOMODULATORS | |
| MA47013A (en) | BENZOLACTAM COMPOUNDS USED AS KINASE PROTEIN INHIBITORS | |
| MA42919A (en) | BICYCLIC COMPOUNDS USED AS ATX INHIBITORS | |
| MA41551A (en) | BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS | |
| MA51878A (en) | AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS | |
| MA53150A (en) | BENZIMIDAZOLE COMPOUNDS AS C-KIT INHIBITORS | |
| MA42918A (en) | BICYCLIC COMPOUNDS USED AS ATX INHIBITORS | |
| EP3768671A4 (en) | IMIDAZOLIDINE-2-ONE DERIVATIVES SUBSTITUTED AS PRMT5 INHIBITORS | |
| MA49374A (en) | HETEROAROMATIC COMPOUNDS USED AS VANINE INHIBITORS | |
| MA52754A (en) | HETEROCYCLIC TRICYCLIC COMPOUNDS AS STING ACTIVATORS | |
| MA45375A (en) | HETEROCYCLIC COMPOUNDS USED AS ANTIBACTERIAL AGENTS | |
| MA53220A (en) | NEW HETEROCYCLIC COMPOUNDS USED AS MONOACYLGLYCEROL LIPASE INHIBITORS | |
| MA55194A (en) | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | |
| MA45377A (en) | HETEROCYCLIC COMPOUNDS AS ANTIBACTERIAL AGENTS | |
| EP3402799A4 (en) | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF RSV | |
| MA46045A (en) | HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS | |
| MA45669A (en) | HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS | |
| MA47576A (en) | BICYCLIC OGA INHIBITOR COMPOUNDS | |
| MA44860A (en) | HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS | |
| EP3768661A4 (en) | DEUTERATED COMPOUNDS USED AS ROCK INHIBITORS |